DGDA Director General (DG) Maj Gen Md Mahbubur Rahman said this on Monday
The Directorate General of Drug Administration (DGDA) has restricted the use of antibiotics for treating patients infected with Covid-19 without the advice of physicians.
DGDA Director General (DG) Maj Gen Md Mahbubur Rahman said this at a press conference in Dhaka on Monday morning.
At the press conference, Delta Pharma Ltd announced to provide 300,000 necessary medicines (tablets) to treat Covid-19 patients. The medicines include Hydroxychloroquine and Azithromycin.
The director general said 100,000 tablets can be used for 20,000 coronavirus affected patients.
Apart from Delta Pharma, other pharmaceutical companies are also ready to supply medicines, he added.
Bangladesh has so far recorded two deaths and 27 infections from Covid-19, a pandemic announced by the World Health Organization (WHO).
The fast spreading coronavirus has claimed more than 14,700 lives and infected over 341,000 people across the world, according to Worldometer.